NL-OMON27197Other不适用
Towards MY smart and intuitive controlled LEG prosthesis: acquisition of electromyography for motion intention detection
Roessingh Research and Development0 个研究点目标入组 70 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- Other
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Individuals without an amputation
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
排除标准
- •Individuals without an amputation:
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
研究者
相似试验
已完成
不适用
Towards MY smart and intuitive controlled LEG prosthesis: acquisition of electromyography for motion intention detectio.v.t.AmputationIndividuals without an amputation10005944NL-OMON55509Revalidatiecentrum Het Roessingh80
已完成
不适用
Towards a smart and intuitive controlled MyLeg prosthesis: acquisition of intramuscular electromyography for motion intention detection. A pilot study.NL-OMON49529Revalidatiecentrum Het Roessingh15
招募中
Unknown
SmartSense4Life - Configurable electronics platform forindividualized rehabilitation after stroke andspinal cord injuryG82.3G82.4G82.5Flaccid tetraplegiaSpastic tetraplegiaTetraplegia, unspecifiedDRKS00032591niversitätsklinikum Heidelberg - Klinik für Paraplegiologie - Sektion Experimentelle Neurorehabilitation3
已完成
不适用
It's LiFe! Innovative monitoring and personalised feedback as a self-management tool in disease management programmes for people with COPD and/or type 2 diabetes; a randomised controlled trial1001265310037454Chronic Obstructive Pulmonary Disease (longziekte)type 2 Diabetes (suikerziekte)NL-OMON39684niversiteit Maastricht240
进行中(未招募)
1 期
A study of Baricitinib in children and young adults with JIA associated eye inflammatioJuvenile Idiopathic Arthritis Associated Uveitis or Anterior Antinuclear Antibody-Positive UveitisMedDRA version: 20.0Level: PTClassification code 10046851Term: UveitisSystem Organ Class: 10015919 - Eye disordersEUCTR2019-000119-10-GBEli Lilly and Company42
